Global warming nears 1.5°C threshold, escalating health risks worldwide

Record temperatures and pollution are escalating health risks worldwide. This report highlights the urgent need for integrated climate and health strategies.

Harmony Biosciences buys small epilepsy biotech for $35M, plus milestones

Rare neurological disease drug developer Harmony Biosciences acquired Epygenix Therapeutics and its pipeline of treatments for rare epilepsy conditions. Harmony paid $35 million upfront, and

May 1, 2024

A previously unknown post-COVID syndrome found

Pradipta Ghosh, M.D., sat down in her office at the University of California San Diego School of Medicine and considered a request from the other

May 10, 2024

Biopharma at a Crossroads: AI Offers Key to R&D Reinvention

What You Should Know: – A new report by Accenture, “Reinventing R&D in the Age of AI,” paints a clear picture: the biopharmaceutical industry stands

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.